Can a Four-Drug cocktail tame pancreatic cancer? a Real-World trial seeks answers
NCT ID NCT07723261
First seen Jul 23, 2026 · Last updated Jul 24, 2026 · Updated 1 time
Summary
This study follows about 70 people with metastatic pancreatic cancer who are receiving NalIriFOx as their first treatment. Researchers are collecting real-world data to see how well the drug combination controls the disease and what side effects occur. The goal is to understand whether this regimen offers meaningful long-term benefits in everyday clinical practice.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- a combination of liposomal irinotecan, 5-fluorouracil, leucovorin, and oxaliplatin (NalIriFOx)
- What this could lead to
- If the data show strong real-world effectiveness, this could support NalIriFOx as a standard first-line option for metastatic pancreatic cancer.
- What could go wrong
- This is an observational study, not a controlled trial, so results may be less definitive. Side effects from the chemotherapy combination can be significant.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for METASTATIC PANCREATIC DUCTAL ADENOCARCINOMA (PDAC) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
2nd Oncology Department, Metropolitan Hospital
RECRUITINGAthens, 185 47, Greece
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Attikon University General Hospital
RECRUITINGAthens, 124 62, Greece
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
General Hospital Agios Andreas
RECRUITINGPátrai, 263 32, Greece
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
General Oncology Hospital Agioi Anargyroi
RECRUITINGAthens, 145 64, Greece
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
HYGEIA Hospital
RECRUITINGAthens, 151 23, Greece
-
HYGEIA Hospital
RECRUITINGAthens, 151 23, Greece
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Ippokratio
RECRUITINGAthens, Greece
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Larissa University General Hospital
RECRUITINGLarissa, Greece
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Thessaloniki General Hospital "George Papanikolaou"
RECRUITINGThessaloniki, 570 10, Greece
Contact Phone: •••-•••-•••• Email: •••••@•••••
More trials for these conditions
Other studies related to the condition(s) this trial covers.